|View printer-friendly version|
|March 21, 2002 4:12 p.m.|
|Teva Announces Resolution of Patent Litigation for Fenofibrate Capsules|
Jerusalem, Israel, March 21, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court of Illinois has granted Summary Judgement of Non-infringement regarding Teva's ANDA for Fenofibrate Capsules (Micronized). This court decision will allow the Food and Drug Administration to approve Teva's ANDA for this product which seeks AB-rating to Abbott's Tricor® Capsules. Tricor® is used in the treatment of patients with very high elevations of serum triglyceride levels.